A Safety Study of SGN-2FF for Patients With Advanced Solid Tumors

Clinical trial NCT02952989 · TERMINATED

Trial details

NCT number: NCT02952989
Sponsor: Seagen Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung Carcinoma, Renal Cell Breast Neoplasms Urinary Bladder Neoplasm Carcinoma, Squamous Cell of Head and Neck Colorectal Neoplasms Gastric Adenocarcinoma Gastroesophageal Junction Adenocarcinoma

Start date: 2017-02-23
Primary completion: 2019-06-24
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.